These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32868198)

  • 1. Efficacy of meropenem and amikacin combination therapy against carbapenemase-producing Klebsiella pneumoniae mouse model of pneumonia.
    Ota K; Kaku N; Yanagihara K
    J Infect Chemother; 2020 Dec; 26(12):1237-1243. PubMed ID: 32868198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.
    Hagihara M; Kato H; Yamashita R; Soda M; Watanabe H; Sakanashi D; Shiota A; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Kitaichi K; Mikamo H
    J Infect Chemother; 2020 Jan; 26(1):1-7. PubMed ID: 31735629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.
    Medeiros GS; Rigatto MH; Falci DR; Zavascki AP
    Int J Antimicrob Agents; 2019 Feb; 53(2):152-157. PubMed ID: 30722960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae.
    Sabet M; Tarazi Z; Nolan T; Parkinson J; Rubio-Aparicio D; Lomovskaya O; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis.
    Tattevin P; Dinh A; Ghout I; Mouton W; Verdier MC; Laurent F; Lemaitre F; Gatin L; Saleh-Mghir A; Crémieux AC
    Int J Antimicrob Agents; 2020 Nov; 56(5):106152. PubMed ID: 32898684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Almarzoky Abuhussain SS; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29914950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing
    Asempa TE; Motos A; Abdelraouf K; Bissantz C; Zampaloni C; Nicolau DP
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of WCK 6777 (ertapenem/zidebactam) against carbapenemase-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model.
    Gethers M; Chen I; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2022 Jun; 77(7):1931-1937. PubMed ID: 35411395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
    Weiss WJ; Pulse ME; Nguyen P; Peterson K; Silva J; Simecka JW; Valtierra D; Sabet M; Griffith DC
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae.
    Jorgensen SCJ; Rybak MJ
    Pharmacotherapy; 2018 Apr; 38(4):444-461. PubMed ID: 29427523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
    Motos A; Yang H; Li Bassi G; Yang M; Meli A; Battaglini D; Cabrera R; Bobi J; Pagliara F; Frigola G; Camprubí-Rimblas M; Fernández-Barat L; Rigol M; Ferrer-Segarra A; Kiarostami K; Martinez D; Nicolau DP; Artigas A; Pelosi P; Vila J; Torres A
    Crit Care; 2023 Feb; 27(1):60. PubMed ID: 36788582
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Hagiya H; Aoki K; Akeda Y; Yamamoto N; Shanmugakani RK; Ishii Y; Tomono K
    Microb Drug Resist; 2019; 25(6):839-845. PubMed ID: 30835635
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
    Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
    Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
    Yu L; Zhang J; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Front Cell Infect Microbiol; 2019; 9():422. PubMed ID: 31921701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae.
    Rivera-Espinar F; Machuca I; Tejero R; Rodríguez J; Mula A; Marfil E; Cano Á; Gutiérrez-Gutiérrez B; Rodríguez M; Pozo JC; De la Fuente C; Rodriguez-Baño J; Martínez-Martínez L; León R; Torre-Cisneros J
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.